One-year follow-up evaluation of approved Subolesin anti-tick vaccine in Uganda.

MLA

Kasaija, Paul D., et al. “One-Year Follow-up Evaluation of Approved Subolesin Anti-Tick Vaccine in Uganda.” Vaccine, vol. 44, Jan. 2025, p. 126562. EBSCOhost, https://doi.org/10.1016/j.vaccine.2024.126562.

APA

Kasaija, P. D., Kabi, F., Semakula, J., Kyakuwa, I., Contreras, M., de la Fuente, G., Rutaisire, J., Mugerwa, S., Gortázar, C., & de la Fuente, J. (2025). One-year follow-up evaluation of approved Subolesin anti-tick vaccine in Uganda. Vaccine, 44, 126562. https://doi.org/10.1016/j.vaccine.2024.126562

Chicago

Kasaija, Paul D, Fredrick Kabi, Jimmy Semakula, Ivan Kyakuwa, Marinela Contreras, Gabriela de la Fuente, Justus Rutaisire, Swidiq Mugerwa, Christian Gortázar, and José de la Fuente. 2025. “One-Year Follow-up Evaluation of Approved Subolesin Anti-Tick Vaccine in Uganda.” Vaccine 44 (January): 126562. doi:10.1016/j.vaccine.2024.126562.